Paweł Sobczuk

Also affiliated with Kettering University, Vall d'Hebron Institut de Recerca, National Institute of Oncology, Vall d'Hebron Hospital Universitari, The Maria Sklodowska-Curie National Research Institute of Oncology, Vall d'Hebron Institute of Oncology

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification”.

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.05.007

N/A

0DataRank · unranked

20 citations

Igor Odintsov, Vladimir Markov, Rebecca Caeser, Paweł Sobczuk, Sam E. Tischfield +14 more